Development and characterization of clarithromycin emulgel for topical delivery

International Journal of Drug Development and Research

Volumn 4, Issue 3, 2012, Pages 310-323

  Baibhav, Joshi ^a   Gurpreet, Singh ^a   Rana, A C ^a   Seema, Saini ^a  

^a Rayat Institute of Pharmacy   (India)

Author keywords

Clarithromycin; Emulgel; Extrudability; Rheological properties; Spreadability

Indexed keywords

AZITHROMYCIN; CARBOPOL 934; CARBOPOL 940; CLARITHROMYCIN; HYDROXYPROPYLMETHYLCELLULOSE; OLEIC ACID; POLYMER;

ANTIMICROBIAL ACTIVITY; ARTICLE; DRUG DELIVERY SYSTEM; DRUG FORMULATION; DRUG RELEASE; DRUG STABILITY; DRUG STRUCTURE; DRUG SYNTHESIS; GEL; HYDROPHOBICITY; MOLECULAR WEIGHT; NONHUMAN; PH; PHYSICAL CHEMISTRY; STAPHYLOCOCCUS AUREUS; VISCOSITY;

EID: 84874292676     PISSN: None     EISSN: 09759344     Source Type: Journal    
DOI: None     Document Type: Article

References (40)

1. Fujii R, Nishimura T. Pharmacokinetics and clinical evaluation of Clarithromycin (TF-031): a new macrolide antibiotic in pediatrics. 28th Interscience Conference. Antimicrobial agents and chemotherapy, Los Angeles CA, 1988 October 23-26.
2. Khan NW, Hassan Fouzia, Naqvi BS, Hasan MF. Antimicrobial activity of Erythromycin and Clarithromycin against clinical isolates of E.coli, Staphylococcus aureus, Klebsiella and Proteus by disc diffusion method. Pak J Pharm Sci 2011;24(1):25-29.
3. Clarithromycin. Available at www.sciencedirect.com. Tuberculosis(2008) 88(2).p.92-95.
4. Parish LC. Clarithromycin in the treatment of skin and skin structure infections: two multicentre clinical studies. Clarithromycin study group. Int J Dermatol 1993; 32: 528-32.
5. Jerry MZ. Macrolides and Ketolides: Azithromycin, Clarithromycin, Telithromycin. Infect Dis Clin N Am 2004; 18: 621-649.
6. Sood KS. Macrolides: Clarithromycin and Azithromycin. Seminars in pediatric infectious disease, vol 10(1) January, 1999: pp.23-30.
7. Sams WW Jr, Lynch PJ. Principles and practice of dermatology. 2nd ed. New York, Churchill Livingstone, 1990.
8. Leung AK, Robosn WL. Acne J Soc Health 1991; 111: 57-60.
9. Bashir A, Mujahid TY, Jehan N. Antibiotic resistance profile: Isolation and characterization of clinical isolates of staphylococci from patients with community- Acquired skin infections. Pak J Pharm Sci 2007; 20(4): 295-299.
10. Mohamed MI. Topical emulsion gel composition comprising diclofenac sodium. Am Assn Pharm Sci 2004; 6(3):1-7.
11. Principle of skin therapy. Website: http//www.dermweb.com/therapy/common.htm. Accessed on 28 May 2011.
12. Joel LZ, Gregory PK. In: Liberman HA, Rieger MM, Banker GS (eds): Pharmaceutical dosage forms: disperse systems, Marcel Dekker, New York, 1989, 2, 502.
13. Amnon C, Shafir B. Transdermal drug delivery using microemulsion and aqueous systems: Influence of skin storage condition on the in vitro permeability of Diclofenac from aqueous vehicle systems. Int J Pharmaceut 2006; 311(1-2): 55-62.
14. Patel GC, Patel MM. Preliminary evaluation of Sesbania seed gum mucilage as gelling agent. Int J Pharm Tech Res 2009; 1(3): 840-843.
15. Kesavan B, Jayaraman A. Lipid nanoparticles for transdermal delivery of flurbiprofen: Formulation in-vitro, ex-vivo and in-vivo studies. Lipids health Dis 2009; 8: 6.
16. Tominaga Naito SH. Percutaneous absorption of Diclofenac sodium ointment. Int J Pharm 1985; 24: 115-124.
17. Wang M, Fang L. Percutaneous absorption of Diclofenac acid and its salt from Emulgel. Asn J Pharmaceut Sci 2008; 3(3): 131-141.
18. Arora P, Mukherjee B. Design Development of Physiochemical and in vitro and in vivo evaluation of Transdermal patches containing Diclofenac diethylammonium salt. J Pharm Sci.2002; 91: 2076-2089.
19. Parsaee S, Sarbolouki MN, Parnianpour M. in vitro release of Diclofenac diethylammonium from lipidbased formulations. Int J Pharm 2002; 241: 185-190.
20. Jain A, Deveda P, Vyas N, Chuhan J, Khambete H, Jain S. Development of antifungal emulsion based gel for topical fungal infection(s). Int J Pharm Res Devp 2011; 2(12): 18-22.
21. Jain A, Gautam SP, Gupta Y, Khambete H, Jain S. Development and characterization of ketoconazole emulgel for topical drug delivery. Der Pharmacia Sinica 2010; 1(3): 221-231.
22. Kaur LP, Garg R, Gupta GD. Development and evaluation of topical gel of Minoxidil from different polymer bases in application of alopecia. Int J Pharm and Pharmaceut Sci. 2010; 2(3): 43-47.
23. Gupta GD, Gaud RS. Release rate of Nimesulide from different gellants. Ind J Pharm Sci 1999; 61: 229-234.
24. Sanjay Jain BD, Padsalg A, Patel K, Mokale V. Formulation development and evaluation of fluconazole gel in various polymer bases. Asn J Pharm 2007; 1: 63-68.
25. Gupta GD, Gaud RS. Release rate of Tenoxicam from Acrypol gel. The Indian Pharmacist 2005; 69-76.
26. Margaret N, Mutimer CR, Hill JA, Murray E. Modern ointment base technology comparative evaluation of bases. J American Pharm Association 1956; 4: 212-217.
27. Basha BN, Prakasam K, Goli D. Formulation and evaluation of Gel containing Fluconazole-Antifungal Agent. Int J Drug Dev Res 2011; 3(4):119-127.
28. Chakole CM, Shende MA, Khadatkar SN, Formulation and development of novel combined halobetasol propionate and fusidic acid ointment. Int J Chem Tech Res 2009; 1: 103-116.
29. Khullar R, Saini S, Rana AC. Emulgels: a surrogate approach for topically used hydrophobic drugs. Int J Pharm Bio Sci 201; 1(3): 117-128.
30. Bhalaria M, Naik S, Misra A. A novel delivery system for antifungal drugs in the treatment of topical fungal disease. Indian J Exp Biol 2009; 47(5): 368-75.
31. Patel VM, Prajapati BG, Patel HV, Patel K. Mucoadhesive bilayer tablets for Propranolol HCL. AAPS Pharm Sci Tech 2007; 8: E1-E6.
32. Kakkar AP, Gupta A. Gelatin based transdermal therapeutic system. Ind Drugs 1992; 29: 308-312.
33. Schreier H, Bouwstra JA. Liposomes and Niosomes as topical drug carriers: Dermal and Transdermal delivery. J Control Rel 1985; 30: 863-868.
34. Obata Y, Takayama K, Maitani Y et al. Effect of ethanol on skin permeation of non ionized and ionized Diclofenac. Int J Pharm 1993; 89: 191-198.
35. Stable topical formulation of Clarithromycin. Appln no-10/498, 407.
36. Adejuwon AO, Ajayi AA, Akintunde OO, Olutiola OP. Antibiotics resistance and susceptibility pattern of a strain of staphylococcus aureus associated with acne. International Journal of Medicine and medical sciences 2010; 2(9): 277-280.
37. Costa P, Manuel J, Lobos Modelling and comparison of dissolution profiles. Eur J Pharm Sci 2001; 13: 123-133.
38. Kabir AKL, Biswas BK, Rouf ASS. Design, fabrication and evaluation of drug release kinetics from aceclofenac matrix tablets using hydroxyl propyl methyl cellulose. Dhaka University J Pharm Sci 2009; 8: 23-30.
39. Gohel MC, Panchal MK, Jogani VV. Novel mathematical method for quantitative expression of deviation from the higuchi model. AAPS Pharm Sci Tech 2000; 1: 1-6.
40. ICH Harmonized Tripartite Guidelines, Stability testing of new drug substances and products, ICH Committee. Federal register 2003; 68: 6571-718.